Plasma Visfatin Concentration as a Surrogate Marker for Visceral Fat Accumulation in Obese Children

[1]  Y. Matsuzawa.  The metabolic syndrome and adipocytokines , 2006, Expert review of clinical immunology.

[2]  A. Shirahata,et al.  High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. , 2006, The Journal of clinical endocrinology and metabolism.

[3]  M. Wolzt,et al.  Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. , 2006, The Journal of clinical endocrinology and metabolism.

[4]  M. Wolzt,et al.  The Adipokine Visfatin is Markedly Elevated in Obese Children , 2006, Journal of pediatric gastroenterology and nutrition.

[5]  J. Fernández-Real,et al.  Serum Visfatin Increases With Progressive β-Cell Deterioration , 2006, Diabetes.

[6]  R. Vettor,et al.  Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. , 2006, The Journal of clinical endocrinology and metabolism.

[7]  M. Wolzt,et al.  The release of the adipocytokine visfatin is regulated by glucose and insulin , 2006, Diabetologia.

[8]  L. Baur,et al.  Comparison of metabolic syndrome prevalence using six different definitions in overweight pre-pubertal children enrolled in a weight management study , 2006, International Journal of Obesity.

[9]  R. Busse,et al.  Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin , 2006, Diabetologia.

[10]  J. Gómez-Reino,et al.  Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[11]  P. Arner.  Editorial: Visfatin—A True Or False Trail To Type 2 Diabetes Mellitus , 2006 .

[12]  J. Fernández-Real,et al.  Serum visfatin increases with progressive beta-cell deterioration. , 2006, Diabetes.

[13]  T. Ohta,et al.  Serum C-reactive protein and its relation to cardiovascular risk factors and adipocytokines in Japanese children. , 2006, The Journal of clinical endocrinology and metabolism.

[14]  P. Arner.  Visfatin--a true or false trail to type 2 diabetes mellitus. , 2006, The Journal of clinical endocrinology and metabolism.

[15]  Shyi-Jang Shin,et al.  Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. , 2006, The Journal of clinical endocrinology and metabolism.

[16]  Y. Matsuzawa.  Metabolic syndrome--definition and diagnostic criteria in Japan. , 2005, Journal of atherosclerosis and thrombosis.

[17]  M. Fasshauer,et al.  Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.

[18]  R. Paschke,et al.  Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. , 2005, American journal of physiology. Endocrinology and metabolism.

[19]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[20]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[21]  A. Vidal-Puig,et al.  Visfatin: the missing link between intra-abdominal obesity and diabetes? , 2005, Trends in molecular medicine.

[22]  N. Klöting,et al.  Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. , 2005, Biochemical and biophysical research communications.

[23]  R. Paschke,et al.  Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. , 2005, The Journal of endocrinology.

[24]  S. Kurtoğlu,et al.  Homeostasis Model Assessment Is More Reliable Than the Fasting Glucose/Insulin Ratio and Quantitative Insulin Sensitivity Check Index for Assessing Insulin Resistance Among Obese Children and Adolescents , 2005, Pediatrics.

[25]  Matthias Blüher,et al.  Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. , 2004, The Journal of clinical endocrinology and metabolism.

[26]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[27]  S. Sugihara,et al.  Criteria for medical intervention in obese children: A new definition of ‘Obesity disease’ in Japanese children , 2003, Pediatrics international : official journal of the Japan Pediatric Society.

[28]  A. Shirahata,et al.  Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. , 2003, Obesity research.

[29]  A. Shirahata,et al.  Increased serum cholesteryl ester transfer protein in obese children. , 2002, Obesity research.

[30]  K. Asayama,et al.  Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys , 2002, International Journal of Obesity.

[31]  J. Arends,et al.  A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization , 1999, FEBS letters.

[32]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[33]  Y. Matsuzawa,et al.  Analysis of an expression profile of genes in the human adipose tissue. , 1997, Gene.

[34]  S. O’Rahilly,et al.  Depot- and Sex-Specific Differences in Human Leptin mRNA Expression: Implications for the Control of Regional Fat Distribution , 1997, Diabetes.

[35]  S. O’Rahilly,et al.  Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. , 1997, Diabetes.

[36]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.